Policy + International Engagement

EBRC works to proactively engage on public policy issues that affect or are affected by the advancement of engineering biology. Through the Policy & International Engagement Working Group, EBRC serves as a focal point for international engagement, representing the U.S. engineering biology community in key international forums and processes. In the U.S., the group engages directly with government stakeholders to provide insight from the research base to promote the economic value of U.S. leadership in the field. Community engagement extends to the local level, to build awareness of research and economic activity and create supportive research environments. EBRC members have access to resources on approaches for effective engagement locally, nationally, and internationally.


EBRC engages with US policy makers to advance early stage engineering biology research in the US.


EBRC is committed to maintaining connections with international partners and finding ways to build a strong, better coordinated global biotechnology community.

Programs & Activities

Activities in Development

EBRC has a number of  activities in development by the Policy & International Engagement Working Group. These activities and programs are currently in the information-gathering and organizational stages and we expect to roll them out soon. If you would like more information about these activities, or would like to contribute, please get in touch.

  • Global Forum for Engineering Biology

    Global Forum for Engineering Biology

    EBRC is actively working with global leaders to facilitate an exchange of information on the nature and scope of engineering biology research worldwide.

    More →

Working Group

Chair: Richard Johnson
Staff Director: Doug Friedman

Policy News

  • February 16, 2019

    U.S. FDA Proposed Rule

    The U.S. FDA has issued a proposed rule on amending the definition of “biological product”. Comments on the proposed rule must be submitted by February 25, 2019. Federal Register.

All Policy News →
Back to top ⇑